Arvinas Inc (ARVN) is destined for greater heights as its last quarter sales were 188,800 K

On Tuesday, Arvinas Inc (NASDAQ: ARVN) opened lower -5.97% from the last session, before settling in for the closing price of $7.87. Price fluctuations for ARVN have ranged from $5.90 to $34.11 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Annual sales at Healthcare sector company slipped by -5.32% over the past five years. Company’s average yearly earnings per share was noted 50.12% at the time writing. With a float of $63.64 million, this company’s outstanding shares have now reached $73.00 million.

Let’s look at the performance matrix of the company that is accounted for 430 employees. In terms of profitability, gross margin is 99.23%, operating margin of -22.39%, and the pretax margin is -10.78%.

Arvinas Inc (ARVN) Insider Updates

A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Arvinas Inc is 12.81%, while institutional ownership is 88.82%. The most recent insider transaction that took place on Jun 24 ’25, was worth 43,377. In this transaction Chief Financial Officer of this company sold 5,700 shares at a rate of $7.61, taking the stock ownership to the 164,401 shares. Before that another transaction happened on Jun 24 ’25, when Company’s Officer proposed sale 5,927 for $7.35, making the entire transaction worth $43,593.

Arvinas Inc (ARVN) Performance Highlights and Predictions

Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.84 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 50.12% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -3.57% during the next five years compared to -5.32% drop over the previous five years of trading.

Arvinas Inc (NASDAQ: ARVN) Trading Performance Indicators

Check out the current performance indicators for Arvinas Inc (ARVN). In the past quarter, the stock posted a quick ratio of 4.58. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.35.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.08, a number that is poised to hit -0.94 in the next quarter and is forecasted to reach -3.11 in one year’s time.

Technical Analysis of Arvinas Inc (ARVN)

Arvinas Inc (NASDAQ: ARVN) saw its 5-day average volume 2.01 million, a negative change from its year-to-date volume of 2.2 million. As of the previous 9 days, the stock’s Stochastic %D was 35.35%.

During the past 100 days, Arvinas Inc’s (ARVN) raw stochastic average was set at 11.32%, which indicates a significant increase from 9.90% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.42 in the past 14 days, which was lower than the 0.63 volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $7.26, while its 200-day Moving Average is $15.64. Nevertheless, the first resistance level for the watch stands at $7.84 in the near term. At $8.27, the stock is likely to face the second major resistance level. The third major resistance level sits at $8.50. If the price goes on to break the first support level at $7.18, it is likely to go to the next support level at $6.95. Assuming the price breaks the second support level, the third support level stands at $6.52.

Arvinas Inc (NASDAQ: ARVN) Key Stats

There are currently 72,991K shares outstanding in the company with a market cap of 540.14 million. Presently, the company’s annual sales total 263,400 K according to its annual income of -198,900 K. Last quarter, the company’s sales amounted to 188,800 K and its income totaled 82,900 K.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.